Literature DB >> 21873353

WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.

Amber L Delmas1, Bridget M Riggs, Carolina E Pardo, Lisa M Dyer, Russell P Darst, Eugene G Izumchenko, Mänette Monroe, Ardeshir Hakam, Michael P Kladde, Erin M Siegel, Kevin D Brown.   

Abstract

Aberrant activation of the Wnt/β-catenin signaling axis is a prominent oncogenic mechanism in numerous cancers including cervical cancer. Wnt inhibitory factor-1 (WIF1) is a secreted protein that binds Wnt and antagonizes Wnt activity. While the WIF1 gene is characterized as a target for epigenetic silencing in some tumor types, WIF1 expression has not been examined in human cervical tissue and cervical cancer. Here, we show that WIF1 is unmethylated and its gene product is expressed in normal cervical epithelium and some cultured cervical tumor lines. In contrast, several cervical cancer lines contained dense CpG methylation within the WIF1 gene, and expression of both WIF1 transcript and protein was restored by culturing cells in the presence of the global DNA demethylating agent 5-aza-2'-deoxycytidine. Using single-molecule MAPit methylation footprinting, we observed differences in chromatin structure within the WIF1 promoter region between cell lines that express and those that do not express WIF1, consistent with transcriptional activity and repression, respectively. The WIF1 promoter was aberrantly methylated in ∼60% (10 of 17) high-grade highly undifferentiated squamous cell cervical tumors examined, whereas paired normal tissue showed significantly lower levels of CpG methylation. WIF1 protein was not detectable by immunohistochemistry in tumors with quantitatively high levels of WIF1 methylation. Of note, WIF1 protein was not detectable in two of the seven unmethylated cervical tumors examined, suggesting other mechanisms may contribute WIF1 repression. Our findings establish the WIF1 gene as a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873353      PMCID: PMC3204350          DOI: 10.1093/carcin/bgr193

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  60 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.

Authors:  S Nakagawa; J M Huibregtse
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase.

Authors:  T Ishidate; A Matsumine; K Toyoshima; T Akiyama
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

4.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites.

Authors:  S Colella; L Shen; K A Baggerly; J P Issa; R Krahe
Journal:  Biotechniques       Date:  2003-07       Impact factor: 1.993

5.  Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma.

Authors:  J Imura; K Ichikawa; J Takeda; T Fujimori
Journal:  Int J Mol Med       Date:  2001-10       Impact factor: 4.101

6.  Frequent alterations of the beta-catenin protein in cancer of the uterine cervix.

Authors:  Ana Laura Pereira-Suárez; Marco Antonio Meraz; Marcela Lizano; Ciro Estrada-Chávez; Fernando Hernández; Primitivo Olivera; Elizabeth Pérez; Patricia Padilla; Moshe Yaniv; Françoise Thierry; Alejandro García-Carrancá
Journal:  Tumour Biol       Date:  2002 Jan-Feb

Review 7.  Secreted antagonists of the Wnt signalling pathway.

Authors:  Yoshiaki Kawano; Robert Kypta
Journal:  J Cell Sci       Date:  2003-07-01       Impact factor: 5.285

Review 8.  Single-molecule analysis of chromatin: changing the view of genomes one molecule at a time.

Authors:  Santhi Pondugula; Michael P Kladde
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

9.  Proteasome-mediated regulation of the hDlg tumour suppressor protein.

Authors:  F Mantovani; P Massimi; L Banks
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.

Authors:  M Ueda; R M Gemmill; J West; R Winn; M Sugita; N Tanaka; M Ueki; H A Drabkin
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

View more
  18 in total

Review 1.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

2.  The small splice variant of HPV16 E6, E6, reduces tumor formation in cervical carcinoma xenografts.

Authors:  Maria Filippova; Whitney Evans; Robert Aragon; Valery Filippov; Vonetta M Williams; Linda Hong; Mark E Reeves; Penelope Duerksen-Hughes
Journal:  Virology       Date:  2014-01-01       Impact factor: 3.616

3.  DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.

Authors:  Smitha R James; Carlos D Cedeno; Ashok Sharma; Wa Zhang; James L Mohler; Kunle Odunsi; Elizabeth M Wilson; Adam R Karpf
Journal:  Epigenetics       Date:  2013-07-09       Impact factor: 4.528

4.  Rapid deamination of cyclobutane pyrimidine dimer photoproducts at TCG sites in a translationally and rotationally positioned nucleosome in vivo.

Authors:  Vincent J Cannistraro; Santhi Pondugula; Qian Song; John-Stephen Taylor
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

5.  DNA methyltransferase accessibility protocol for individual templates by deep sequencing.

Authors:  Russell P Darst; Nancy H Nabilsi; Carolina E Pardo; Alberto Riva; Michael P Kladde
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 6.  Targeting the WNT Signaling Pathway in Cancer Therapeutics.

Authors:  David Tai; Keith Wells; John Arcaroli; Chad Vanderbilt; Dara L Aisner; Wells A Messersmith; Christopher H Lieu
Journal:  Oncologist       Date:  2015-08-25

7.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

8.  Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.

Authors:  Elisa M Jorgensen; Myles H Alderman; Hugh S Taylor
Journal:  FASEB J       Date:  2016-06-16       Impact factor: 5.191

Review 9.  Targeting Wnt Signaling in Endometrial Cancer.

Authors:  Iram Fatima; Susmita Barman; Rajani Rai; Kristina W W Thiel; Vishal Chandra
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

10.  Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus.

Authors:  Russell P Darst; Irina Haecker; Carolina E Pardo; Rolf Renne; Michael P Kladde
Journal:  Nucleic Acids Res       Date:  2013-01-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.